Risk Factors for Occult Mediastinal Metastases in Clinical Stage I Non-Small Cell Lung Cancer
- 1 July 2007
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (1) , 177-181
- https://doi.org/10.1016/j.athoracsur.2007.03.081
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-term survival and recurrence in patients with resected non–small cell lung cancer 1 cm or less in sizeThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Location as an important predictor of lymph node involvement for pulmonary adenocarcinomaThe Journal of Thoracic and Cardiovascular Surgery, 2006
- The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survivalThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer ResectionJournal of Clinical Oncology, 2004
- A comparative analysis of positron emission tomography and mediastinoscopy in staging non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?The Annals of Thoracic Surgery, 2002
- The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor modelsNuclear Medicine and Biology, 1996
- Survival in early-stage non-small cell lung cancerThe Annals of Thoracic Surgery, 1995